Introduction
============

Uridine 5′-diphosphate [d]{.smallcaps}-xylose (UDP-xylose; UDP-Xyl) is the donor substrate of xylosyltransferases (XylT) that transfer a xylosyl moiety to different acceptor molecules in the biosynthesis of glycoconjugates. Proteoglycan biosynthesis, for example, is initiated through transfer of a xylosyl residue to the protein acceptor. Xylosyl-containing glycoconjugates play central roles in different cellular processes including signalling, virulence or build-up of the cell wall and the extracellular matrix.\[[@b1]\] In nature, UDP-Xyl is produced by UDP-xylose synthase (UXS; EC 4.1.1.35) *via* oxidative decarboxylation of UDP-glucuronic acid (UDP-GlcUA).\[[@b2]\] UDP-glucose dehydrogenase (UGDH; EC 1.1.1.22) synthesizes UDP-GlcUA in a NAD^+^-dependent two-step oxidation of UDP-glucose (UDP-Glc).\[[@b3]\] UDP-Glc is ultimately derived from glucose *via* the glycolytic intermediate glucose 6-phosphate and glucose 1-phosphate.\[[@b4]\]

Besides its important biological function, UDP-Xyl is a valuable chemical that finds use as substrate for XylT in different research applications. UDP-Xyl is needed for enzyme activity profiling and *in vitro* enzyme characterization. It is also used for *in vivo* studies of XylT function in cell biology and tissue development. UDP-Xyl is an important ligand and inhibitor of enzymes other than XylT, UGDH, for example.\[[@b5]\] To support the different fields in glycobiology research with UDP-Xyl, therefore, an efficient supply of anomerically pure compound would be desirable.\[[@b6]\] However, while synthesis methods for some nucleotide sugars (e.g., UDP-Glc) are well established, synthetic routes or pathways to UDP-Xyl are rare.\[[@b4c],[@b7]\] Although several research groups have enzymatically prepared UDP-Xyl *in vitro*, the resulting product was rarely purified and/or isolated.\[[@b7],[@b8]\]

Generic ways of nucleotide sugar synthesis are shown in Scheme [1](#sch01){ref-type="scheme"}.\[[@b7]\] Starting from a monosaccharide as in route (**1**), the product is synthesized enzymatically in two steps, where in the first step (a) a diastereoselective kinase forms an α-configured sugar 1-phosphate using a nucleoside triphosphate donor. The sugar 1-phosphate is then converted into the desired nucleotide sugar *via* step (b) or (c). Catalytic reaction (b) involves a nucleotidyltransferase where nucleoside triphosphate (here: UTP) is the second substrate. However, use of the nucleotidyltransferase reaction constitutes a potentially critical issue in the overall synthetic route, because transformations are often characterized by a highly unfavorable reaction equilibrium, as well as inhibition by pyrophosphate released from nucleoside triphosphate.\[[@b9]\] Provision of thermodynamic "pull" from a coupled reaction where pyrophosphatase (d) is used to catalyze hydrolysis of the pyrophosphate presents a possible solution, but further enhances complexity of the reaction system. Glycosyl exchange with a nucleotide sugar (c) is another approach, but also depends on a nucleotidyltransferase exhibiting a back reaction.

![Generic methods of nucleotide sugar synthesis, exemplified for UDP-Xyl preparation (Xyl-1-P: α-[d]{.smallcaps}-xylose 1-phosphate, Glc-1-P: α-[d]{.smallcaps}-glucose 1-phosphate).](adsc0356-3575-f6){#sch01}

The same synthetic route (**1**) is also pursued with purely chemical methods (a′--b′)\[[@b10]\] or chemo-enzymatically (e.g., a′--c). A recent example for chemical UDP-Xyl synthesis following route (b) is the strategy by Ishimizu et al.\[[@b6]\] where pure UDP-α-Xyl was prepared from activated UMP and xylose 1-phosphate. A yield of 35% after a relatively long reaction time of five days was reported. Errey et al. showed a chemo-enzymatic method for production of UDP-Xyl and also of other UDP sugars according to route (a′--c).\[[@b8h]\] UDP-Xyl was enzymatically prepared from chemically synthesized xylose 1-phosphate on a small 500 μL scale (37.5 g [l]{.smallcaps}^−1^). Chemical methods for UDP-Xyl synthesis starting from [d]{.smallcaps}-xylose have also been established, but they often lead to anomeric mixtures of the product.\[[@b11]\] Additionally, *in vivo* enzymatic approaches starting from [d]{.smallcaps}-glucose have been reported. For example, Yang et al. used engineered *Escherichia coli* cells for production of various NDP sugars, including UDP-Xyl.\[[@b8g]\]

When an already available nucleotide sugar is used as substrate for UDP-Xyl synthesis, the target molecule is formed either by direct conversion (e.g., sugar oxidation) or in several steps, as shown in route (**2**).\[[@b7]\] Oka et al. established route (**2**) in the yeast *Saccharomyces cerevisiae* where engineered cells synthesized UDP-Xyl from the naturally present UDP-Glc.\[[@b8i]\] From the very limited number of reports about pure UDP-Xyl preparation, the need for an efficient and convenient synthesis is evident. In particular, the preparation of anomerically pure UDP-Xyl is a problem requiring special attention. We present herein a new enzymatic *in vitro* approach according to route (**2**) in Scheme [1](#sch01){ref-type="scheme"}. In analogy to the natural biosynthetic pathway, UDP-Glc is converted to UDP-Xyl by UGDH and UXS. Both enzymes exhibit no observable back reaction, which presents a clear advantage in having eliminated thermodynamic restrictions of the nucleotidyltransferase-catalyzed conversion. Comprehensive step-by-step reaction analysis and optimization enabled us to set up an effective biocatalytic system for the production of pure UDP-α-Xyl. The results provide a strong case for synthetic use of multi-step redox cascades in the preparation of nucleotide sugar products.

Results and Discussion
======================

The herein presented system consists of a two-step conversion of UDP-Glc to UDP-Xyl *via* UDP-GlcUA catalyzed by UGDH and UXS, as shown in Scheme [2](#sch02){ref-type="scheme"}. Human enzymes (hUGDH and hUXS) were used to accomplish this task. We coupled the hUGDH reaction to a coenzyme regeneration cascade making use of *Candida tenuis* xylose reductase (*Ct*XR) and bovine liver catalase.\[[@b12]\] Thermodynamic and kinetic requirements as well as cost considerations had to be taken into account, as regeneration of NAD^+^ is not well established, compared to NADH.\[[@b13]\] We applied a system originally described by Pival et al., in which *Ct*XR reduces 9,10-phenanthrenequinone (PQ) to 9,10-phenanthrene hydroquinone (PQH~2~).\[[@b12]\] The NADH produced in UDP-Glc oxidation is recycled to NAD^+^ during PQ reduction. PQH~2~ is spontaneously re-oxidized by molecular oxygen in a fast radical chain reaction. Finally, catalase cleaves the thus produced hydrogen peroxide. The thermodynamically highly favorable reduction of oxygen provides a strong driving force that keeps the cycle running.\[[@b12]\] For that purpose, the development of an effective oxygen supply method was crucial.

![Chemo-enzymatic cascade transformation employed for synthesis of UDP-Xyl (3) from UDP-Glc (1) *via* UDP-GlcUA (2) through the combined action of hUGDH, hUXS, *Ct*XR and bovine catalase. The coupling of the hUGDH reaction to *Ct*XR-based NAD^+^ regeneration strongly improves efficiency of the system. Oxidation of PQH~2~ (4) to PQ (5) is coupled to H~2~O~2~ decomposition for *in situ* O~2~ supply, leading formally to oxidative decarboxylation of UDP-Glc to UDP-Xyl by H~2~O~2~.](adsc0356-3575-f7){#sch02}

The second main task in developing this multi-enzyme multi-reaction system of UDP-Xyl synthesis in one pot was the optimization of various interrelated reaction parameters. Comprehensive analysis of thermodynamic, kinetic and stability effects on each reaction of the overall system was necessary, and it turned out that overcoming inhibition effects was especially important. UXS is inhibited by UDP-Xyl, UGDH is inhibited by UDP-Xyl and also by NADH.\[[@b7],[@b14]\] Till now, these inhibitions constituted a major restriction in enzymatic *in vitro* synthesis of not only UDP-Xyl, but also UDP-GlcUA.\[[@b7]\]

Engineering of Reaction Parameters
----------------------------------

The initial idea was to perform the synthesis as a "one-pot one-step" conversion, where all enzymes are present right from the beginning. However, conversion of 20 mM UDP-Glc stopped after production of only 2 mM UDP-Xyl (data not shown). The most likely cause for the low yield was inhibition of hUGDH, as it has been reported that full inhibition of UGDH can be accomplished by only 50 μM UDP-Xyl.\[[@b5]\] Therefore, we switched to a "one-pot two-step" reaction and separated UDP-GlcUA and UDP-Xyl production by adding hUXS only after UDP-Glc was fully consumed.

The first step (UDP-Glc→UDP-GlcUA) depends on the combined action of hUGDH, *Ct*XR and bovine catalase. It was therefore crucial to find conditions suited for all three enzymes in order to establish an efficient synthetic system. As catalase activity is invariant over a large pH range (4.0--8.5) and the enzyme was employed in large excess, it was readily used in the synthesis without further testing or optimization.\[[@b15]\] Therefore, it was primarily necessary to match hUGDH and *Ct*XR reactions, which was done by adaption of buffer, temperature and pH conditions.

Because potassium phosphate buffer was known to be compatible with both hUGDH and *Ct*XR,\[[@b3],[@b12]\] it was used in the synthesis experiments. Next, we determined the influence of different temperatures on UDP-Glc conversion. The *Ct*XR-based coenzyme recycling system had previously been developed at 25 °C, and stability of the reductase enzyme decreases above 30--35 °C.\[[@b11],[@b16]\] However, an increase in reaction temperature from 25 °C to 37 °C during multi-enzymatic UDP-Glc conversion improved both reaction time and yield (data not shown). Based on these results, 37 °C was used in the UDP-Glc→UDP-GlcUA step.

Last, pH-activity dependencies of hUGDH and *Ct*XR at synthesis temperature were examined. We tested activities of both enzymes in the pH range 6.0 to 8.5 at 37 °C (Figure [1](#fig01){ref-type="fig"}A). Although the pH optimum of hUGDH was distinctly higher than that of *Ct*XR, at pH 7.5 both enzymes exhibited sufficiently high activity for the coupled enzymatic conversion.

![A) pH-activity dependencies of *Ct*XR and hUGDH. At pH 7.5 both enzymes show satisfactory activity. B) Comparison of UDP-GlcUA conversion by hUXS (30 μM) at 25 °C and 37 °C, showing the beneficial effect of the higher reaction temperature.](adsc0356-3575-f1){#fig01}

Investigation of hUXS, the only enzyme involved in the second step (UDP-GlcUA→UDP-Xyl), revealed that the enzyme also showed faster conversion and higher yield at 37 °C than at 25 °C using potassium phosphate buffer (Figure [1](#fig01){ref-type="fig"}B). We thus chose to not change the reaction conditions prior to hUXS addition in the complete reaction system.

Engineering of UDP-Glc Conversion
---------------------------------

Without efficient regeneration of the coenzyme, the conversion of UDP-Glc to UDP-GlcUA would be unfavorable for synthetic purposes (see Scheme [2](#sch02){ref-type="scheme"}). One commonly chosen group of enzymes to accomplish this task are water-forming NADH oxidases that use molecular oxygen to convert NADH to NAD^+^.\[[@b17]\] However, their operational stability can be an issue under conditions of coenzyme recycling, for example, they are prone to inactivation by oxidizing agents.\[[@b12],[@b18]\] We therefore used a modification of the method described by Pival et al. (Scheme [2](#sch02){ref-type="scheme"}), who used an enzymatic cascade to mimic the NADH oxidase reaction, and thus circumvented the known stability problems.\[[@b12]\] In this cascade reaction, the most critical point is an adequate oxygen supply for radical oxidation of PQH~2~ to PQ (see Scheme [2](#sch02){ref-type="scheme"}) that was previously achieved by membrane gassing.\[[@b12]\] We investigated a new approach of oxygenation that is based on the "chemical oxygen source" H~2~O~2~. Underlying rationale was to achieve higher efficiency and easier parallelization and handling of the system. High catalase activity (100 U/mL) in combination with periodic feeding of H~2~O~2~ was used to realize fast *in situ* oxygen production (Scheme [2](#sch02){ref-type="scheme"}). Fast turnover of H~2~O~2~ was also necessary to prevent instability of hUGDH. 20 mM H~2~O~2~ led to a 50% reduction in initial activity and inactivation of the enzyme after only 1 min. In contrast, *Ct*XR was not affected by the oxidant, as already described previously.\[[@b12]\]

Initially, we investigated the use of 250 μM NAD^+^ for conversion of 20 mM UDP-Glc. However, with these parameters substrate conversion was below 50%. As the UGDH reaction is considered irreversible in the UDP-GlcUA direction,\[[@b7]\] this effect was not due to equilibrium, but rather due to the *K*~i~ of 27 μM for NADH.\[[@b14]\] The low conversion was therefore ascribed tentatively to accumulation of NADH. Inactivation of *Ct*XR during the synthetic reaction (Figure [2](#fig02){ref-type="fig"}A) was a plausible reason for the gradual increase in NADH during the reaction. In combination with the low initial NAD^+^ concentration, the reaction would quickly come to a halt. However, *Ct*XR was already employed in high excess over hUGDH (12 U/mL *vs.* 0.9 U/mL initial activity). Therefore, a further increase in *Ct*XR concentration did not seem meaningful and we rather evaluated the influence of higher NAD^+^ concentrations on overall UDP-Glc conversion to overcome the problem of enzyme inhibition. The use of 1 mM NAD^+^ still resulted in progressive slowdown of the reaction and incomplete conversion even after 5 h. At 2 mM NAD^+^, by contrast, UDP-Glc was fully converted after only 3 h (Figure [2](#fig02){ref-type="fig"}B). Therefore, the latter concentration of was used in subsequent syntheses.

![A) *Ct*XR inactivation during biocatalytic synthesis of UDP-GlcUA (t~1/2~=150 min). B) Effect of NAD^+^ concentration on conversion of UDP-Glc when 10 μM hUGDH were used. Full conversion was only achieved with 2 mM NAD^+^, not with 1 mM. C) Effect of *Ct*XR concentration on conversion. No change in UDP-Glc conversion (10 μM hUGDH) was observed regardless of whether 10 μM, 5 μM or 2 μM *Ct*XR were used. The NAD^+^ concentration was 2 mM.](adsc0356-3575-f2){#fig02}

However, the high excess of *Ct*XR was considered economically unfavorable, and, as shown above, the use of a higher NAD^+^ concentration seemed more likely to be beneficial for UDP-GlcUA yield. We thus investigated the effect of lowering *Ct*XR concentration with regard to reaction time and completeness of conversion. No significant change in UDP-Glc conversion was noticed upon decreasing the *Ct*XR concentration from 10 μM to 2 μM (Figure [2](#fig02){ref-type="fig"}C). In contrast, lowering the hUGDH concentration by 50% led to incomplete conversion of UDP-Glc (60%) and was not considered in further experiments (Supporting Information, [Figure S1](#SD1){ref-type="supplementary-material"}).

In all experiments, a UDP-Glc concentration of 20 mM was used. Attempts to use a higher concentration (e.g., 40 mM) failed and only about 50% conversion were reached (Supporting Information, [Figure S2](#SD1){ref-type="supplementary-material"}). This effect occurred most probably due to a large pH drop during UDP-GlcUA production (about one pH unit per 20 mM UDP-Glc converted), strongly decreasing hUGDH activity (see Figure [1](#fig01){ref-type="fig"}A). Using a higher buffer concentration to maintain a stable pH interfered with activities of both hUGDH and *Ct*XR and was not further pursued (Supporting Information, [Figure S3](#SD1){ref-type="supplementary-material"}). Automated pH control would constitute a solution when working with larger reaction volumes; however, in the low volume of 1 mL used herein, the approach was not considered to be practical.

Engineering of UDP-GlcUA Conversion
-----------------------------------

The second part of the biosynthetic reaction consisted of direct conversion of UDP-GlcUA to UDP-Xyl, with the only by-product being CO~2~ (Scheme [2](#sch02){ref-type="scheme"}). The hUXS reaction was not affected by the pH drop from 7.5 to about 6.5--6.7 during UDP-GlcUA synthesis. Even without adjusting the pH prior to addition of the enzyme, UDP-Xyl yield was approximately 90% at the end of the reaction (data not shown). The incomplete UDP-GlcUA conversion was most probably caused by a combination of hUXS inhibition by UDP-Xyl, as already reported for UXS,\[[@b7]\] and enzyme inactivation. We therefore doubled hUXS concentration to 30 μM, which indeed led to full conversion of UDP-GlcUA to UDP-Xyl within 24 h (see the next section).

Preparative UDP-Xyl Synthesis
-----------------------------

Using the previously optimized parameters and conditions, a highly efficient biocatalytic reaction system for UDP-Xyl production could be set up. The time course of the reaction is depicted in Figure [3](#fig03){ref-type="fig"}, reaction conditions are summarized in Table [1](#tbl1){ref-type="table"}. Twenty millimoles of UDP-Glc/L were nearly fully (\> 97.5%) and highly reproducibly (standard deviation in triplicate experiment \<3%) converted to UDP-Xyl within 29 h. Already after 3.5 h, residual UDP-Glc concentration was \<1% (0.23±0.04 mM), and the UDP-GlcUA produced was readily transformed to UDP-Xyl after addition of hUXS.

![Time course of biocatalytic UDP-Xyl production (data from triplicate experiments). Concentrations of UDP-Glc, UDP-GlcUA and UDP-Xyl are shown (left ordinate). The yellow line depicts the total amount of H~2~O~2~ added to the reaction mixture. hUXS was added at the time indicated, after UDP-Glc was consumed.](adsc0356-3575-f3){#fig03}

###### 

Reaction conditions of UDP-Xyl production

  UDP-Glc   NAD^+^   PQ   H~2~O~2~^\[a\]^   BSA   hUGDH   hUXS   CtXR   Catalase   V   T    pH
  --------- -------- ---- ----------------- ----- ------- ------ ------ ---------- --- ---- -----
  20        2        25   20                1     10      30     2      100        1   37   7.5

^\[a\]^ Concentration in reaction tube after feeding H~2~O~2~ (see text).

H~2~O~2~ was added batch-wise, as shown in Figure [3](#fig03){ref-type="fig"}. A total amount corresponding to 100 mM H~2~O~2~ was added for full conversion of 20 mM substrate, indicating that 40% of the generated oxygen were consumed in the reaction. Most likely gaseous oxygen was lost through the polypropylene (PP) reaction tube, as PP is highly oxygen permeable.\[[@b19]\] Usage of a tightly sealed, less oxygen permeable reaction vessel (e.g., PVC, PET) could be used to improve efficiency.\[[@b19]\] However, H~2~O~2~ does not contribute significantly to UDP-Xyl production costs due to its low price compared to the product (\>45 US \$/mg).\[[@b20]\] In Figure [3](#fig03){ref-type="fig"} it is also visible that the hUXS reaction slowed down considerably after reaching about 50% conversion (see before), but still gained 98% conversion within a reasonable time. With this system, a total amount of 10.5 mg UDP-Xyl could be produced in one reaction batch and, due to the simple process set up, numbering up would easily be accomplishable.

We also determined total turnover numbers (TTN) of different compounds in the reaction to facilitate evaluation of the system (Table [2](#tbl2){ref-type="table"}). Pival et al. reached a TTN~PQ~ of 1000 in conversion of 25 mM substrate, which fits well to the value obtained here (TTN~PQ~=780, c~substrate~=20 mM).\[[@b12]\] Therefore, this indicates that the approach of feeding H~2~O~2~ is at least equally effective as membrane gassing. TTN values for NAD^+^ and *Ct*XR are lower than those reported by Pival et al. due to the aforementioned inhibitory effects that occur during reaction. Nevertheless, the system provides a significant improvement over the use of stoichiometric amounts of the coenzyme.

###### 

Characteristics of UDP-Xyl production

  hUGDH   hUXS   *Ct*XR   NAD^+^   PQ         
  ------- ------ -------- -------- ---- ----- ----
  1950    650    9750     10       40   780   40

^\[a\]^ Total turnover number (mM UDP-Xyl produced per mM of compound consumed).

^\[b\]^ Number of regeneration cycles

Purification and Isolation of UDP-Xyl
-------------------------------------

After biocatalytic synthesis, a two-step chromatographic protocol was used to purify UDP-Xyl. In the first step, anion exchange chromatography (AEX) was employed to separate UDP-Xyl from other compounds of the reaction mixture. Subsequently, the salt used for elution was removed by size exclusion chromatography (SEC). To minimize total loading on the column and thereby improve separation and sugar binding capacity, proteins (hUGDH, hUXS, *Ct*XR, BSA and catalase) were removed by membrane filtration prior to AEX, as described in the Experimental Section.

In AEX an ammonium formate (NH~4~HCO~2~) buffer (pH 4.2) was used as mobile phase. By applying a step-wise gradient between 20 mM and 500 mM NH~4~HCO~2~, resolution of the reaction mixture was possible within 18 min (Figure [4](#fig04){ref-type="fig"}A). UDP-Xyl eluted separately from other compounds at 105 mM NH~4~HCO~2~ (σ=17 mS⋅cm^−1^).

![A) Anion exchange chromatography. The reaction mixture was loaded on a Resource Q column and eluted using a NH~4~HCO~2~ gradient. The peak inside the black box is UDP-Xyl. B) Size exclusion chromatography: UDP-Xyl-containing fractions from AEX were concentrated and applied to a Sephadex G-10 column. Elution with deionized water led to pure UDP-Xyl (black box).](adsc0356-3575-f4){#fig04}

For removal of NH~4~HCO~2~ and water in one step, lyophilization can be used. However, it is reported that nucleotide sugars are prone to decomposition under such conditions.\[[@b21]\] Therefore, we used SEC to separate NH~4~HCO~2~ from UDP-Xyl and evaluated different SEC stationary phases (Bio-Gel P-2 from Bio-Rad; Sephadex G-25 and Sephadex G-10 from GE Healthcare) in combination with elution by deionized water. As UDP-Xyl seemed to adsorb to Bio-Gel P-2 (polyacrylamide), this resin was unsuitable. Sephadex G-25 (dextran) led to good separation, however with some overlap between UDP-Xyl and NH~4~HCO~2~ (Supporting Information, [Figure S4](#SD1){ref-type="supplementary-material"}). In order to improve product recovery, the finer Sephadex G-10 material (exclusion limit=700 Da *vs.* 1000 Da for G-25) was chosen. With this method, nearly full separation of UDP-Xyl and NH~4~HCO~2~ could be achieved (Figure [4](#fig04){ref-type="fig"}B).

UDP-Xyl was finally isolated from the aqueous solution by removal of water under reduced pressure. It was previously confirmed that the chosen conditions do not lead to decomposition of the product. Within some hours, UDP-α-Xyl was obtained as its ammonium salt (white to yellow powder, see Supporting Information, [Figure S5](#SD1){ref-type="supplementary-material"}). Identity of the product was confirmed by ^1^H NMR (Figure [5](#fig05){ref-type="fig"}), and capillary zone electrophoresis (Supporting Information, [Figure S6](#SD1){ref-type="supplementary-material"}) showed a purity of 98%. The total amount obtained from one reaction batch was 5.3 mg, corresponding to an isolated yield of 46% (compared to the end of biocatalytic synthesis).

![^1^H NMR spectrum of purified UDP-Xyl. Signals of sugar protons H-1 to H-5 were assigned according to the literature, impurities are indicated by an asterisk.\[[@b8]\] Only a small formate signal is visible at 8.43 ppm,\[[@b22]\] indicating nearly complete removal of NH~4~HCO~2~ during purification (Supporting Information, [Figure S7](#SD1){ref-type="supplementary-material"}).](adsc0356-3575-f5){#fig05}

Conclusions
===========

We have established a highly efficient multi-enzyme multi-step transformation for the synthesis of the rare and also expensive UDP-Xyl from the well available and comparably expedient substrate UDP-Glc. Conversion of UDP-Glc was achieved by coupling a two-step synthetic reaction cascade to a chemo-enzymatic coenzyme regeneration cascade, as shown in Scheme [2](#sch02){ref-type="scheme"}. We show that in-depth analysis of each individual reaction in combination with careful optimization work was important to bring the complex multi-component system to the point of truly effective performance. One key feature of conversion efficiency was *in situ* O~2~ production from H~2~O~2~ as the actual chemical oxidant supplied to the overall reaction. Separation in time of the catalytic action of hUXS from that of hUGDH was also critical for high synthesis rates and complete conversion. Fast chromatographic work-up of the reaction mixture lead to highly pure UDP-Xyl in good yield.

As there exist several well established systems for UDP-Glc synthesis based on assembly of UDP-Glc from glucose and UTP,\[[@b23]\] our system could be expanded by coupling one of these methods to the herein described UDP-Xyl synthesis. This would reduce the costs of UDP-Xyl synthesis even further. Additionally, our system also offers an efficient way to UDP-GlcUA, a compound whose synthesis was equally difficult to achieve till now.\[[@b7]\] We also believe that synthesis of UDP-Xyl provides a strong case supporting the use of multi-step enzymatic cascades in the preparation of high-value products such as nucleotide sugars.

Experimental Section
====================

Chemicals and Strains
---------------------

UDP-glucose (\>90% purity) was purchased from Carbosynth (Compton, UK), UDP-glucuronic acid (\>98% purity), 9,10-phenanthrenequinone (\>99% purity), bovine serum album (BSA; \>98% purity) and bovine catalase (3809 U/mg) from Sigma--Aldrich (Vienna, Austria). NAD^+^ (\>98% purity) was obtained from Roth (Karlsruhe, Germany). *Aspergillus niger* glucose oxidase type VII-S (GOD; 246 U/mg) and horseradish peroxidase type II (POD; 181 U/mg) were purchased from Sigma--Aldrich. All other chemicals were purchased either from Sigma--Aldrich or Roth and were of the highest purity available.

Design and assembly of the recombinant *Escherichia coli* strains for hUGDH, hUXS and *Ct*XR expression are described elsewhere.\[[@b2],[@b3],[@b12]\]

Enzyme Expression and Purification
----------------------------------

Expression and purification of the recombinant hUGDH, hUXS and *Ct*XR are described in full detail elsewhere.\[[@b2],[@b3],[@b12]\] Briefly, the enzymes were overexpressed in *E. coli* Rosetta 2(DE3) using a pBEN- (hUGDH), p11- (hUXS) or pQE-30- (*Ct*XR) derived expression vector. After high-pressure cell disruption, His-tagged hUXS and *Ct*XR were isolated from the crude extract using a Cu^2+^-loaded IMAC sepharose column (GE Healthcare, Vienna, Austria), while a Strep-Tactin sepharose column (QIAGEN, Hilden, Germany) was used for Strep-tagged hUGDH. Elution with imidazole (His-tag) or desthiobiotin (Strep-tag) yielded highly pure enzymes (checked by SDS-PAGE). Buffer exchange to remove imidazole or desthiobiotin was done using Vivaspin centrifugal concentrators (Sartorius Stedim, Göttingen, Germany). Enzyme preparations were stored at −70 °C.

Enzymatic Assays
----------------

Activities of hUGDH and *Ct*XR were determined by monitoring NADH formation (hUGDH) or consumption (*Ct*XR) on a Beckman-Coulter DU800 spectrophotometer (*λ*=340 nm) with temperature-controlled sample holder (37 °C). Assays for hUGDH contained 0.1 μM enzyme, 0.5 or 1 mM UDP-Glc and 5 or 10 mM NAD^+^ in 50 mM potassium phosphate buffer (PPB) (pH 7.5), for *Ct*XR 0.05 μM enzyme, 50 μM PQ and 250 μM NADH in the same buffer were used. hUXS was assayed using 5 μM enzyme, 5 mM UDP-GlcUA and 0.5 mM NAD^+^ in 50 mM PPB (pH 7.5). In this case, results were obtained by measuring UDP-GlcUA consumption on HPLC or CE.

Enzyme activities during biocatalytic synthesis were measured by diluting a sample 1:100 (hUGDH) or 1:200 (*Ct*XR) in 50 mM PPB (pH 7.5) containing 5 mM NAD^+^ (hUGDH) or 50 μM PQ (*Ct*XR). Reactions were started by addition of 1 mM UDP-Glc (hUGDH) or 250 μM NADH (*Ct*XR) and followed by monitoring the change in NADH concentration as described above.

The pH-activity dependencies of hUGDH and *Ct*XR were determined by measuring activity as described above using 50 mM PPB in the pH range 6.0--8.5.

Biocatalytic Synthesis
----------------------

Unless otherwise stated, reaction mixtures for UDP-Xyl biosynthesis contained 20 mM UDP-Glc, 2 mM NAD^+^, 25 μM PQ, and 0.1% (w/v) BSA in 50 mM PPB (pH 7.5). Enzymes were added in the following order: 100 U/mL bovine liver catalase, 2 μM *Ct*XR. All experiments were done on a Thermomixer Comfort (Eppendorf, Hamburg, Germany) at 37 °C without agitation. The reaction mixture was incubated for several minutes before reaction was started by addition of 10 μM hUGDH followed by immediate addition of 20 mM H~2~O~2~, mixing, and closing of the 1.5-mL Eppendorf reaction tube cap. Total reaction volume was 1 mL.

20 μL samples were taken at the beginning and the indicated time points. After each sample, H~2~O~2~ was added to a concentration of 20 mM, until UDP-Glc was fully consumed. 30 μM hUXS were added to the mixture afterwards and the reaction was allowed to proceed to completeness.

High Performance Liquid Chromatography
--------------------------------------

Samples were analyzed on an Agilent 1200 HPLC system equipped with a 5 μm Zorbax SAX analytical HPLC column (4.6×250 mm; Agilent, Santa Clara, CA, USA) and a UV detector (*λ*=262 nm). Reactions were stopped by heating the samples to 99 °C for 5 min and precipitated enzymes were removed by centrifugation (16000 *g* for 5 min). The supernatant was diluted 1:20 with 50 mM PPB (pH 7.5) and measured using an injection volume of 10 μL, a temperature of 25 °C and a flow rate of 1.5 mL min^−1^. Elution was performed with a linear gradient from 5 mM to 300 mM PPB (pH 3.2) over 10 min. The column was washed (3 min each) with 600 mM and 5 mM PPB (pH 3.2) after each analysis. Authentic standards were used for calibration.

Capillary Zone Electrophoresis
------------------------------

Capillary zone electrophoresis analyses were performed at 18 °C on an HP 3D CE system (Hewlett Packard, Palo Alto, CA, USA) equipped with an extended light path fused silica capillary (5.6 μm×56 cm) from Agilent and a diode array detector (*λ*=262 nm). The electrophoresis buffer was 20 mM sodium tetraborate (pH 9.3). The capillary was conditioned each day using the following protocol: 10 min NaOH 1 M, 10 min NaOH 0.1 M, 10 min H~2~O, 15 min electrophoresis buffer. Prior to each sample, the capillary was pre-conditioned with 2 min H~2~O, 2 min NaOH 0.1 M, 3 min H~2~O and 10 min electrophoresis buffer. Samples were injected by pressure (50 mbar, 5 s) and measured using a protocol with a voltage of 30 kV for 10 min, 15 kV for 3 min and 30 kV for 8 min. Preparation of the samples was done according to HPLC analysis except that caffeine was added as internal standard. Authentic standards were used for calibration.

Proton NMR Spectroscopy
-----------------------

Spectra were recorded on a Bruker DRX-600 AVANCE spectrometer (Bruker, Rheinstetten, Germany) at 600.13 MHz (^1^H). The ^1^H NMR spectra were measured at 298.2 K with acquisition of 32 k data points. After zero filling to 64 k data points, spectra were performed with a range of 7200 Hz. 32 ^1^H NMR spectra were recorded in one measurement, using a 5 mm high precision NMR sample tube (Promochem, Wesel, Germany). For evaluation of the spectra ACD/NMR Processor Academic Edition 12.0 (Advanced Chemistry Development Inc., Toronto, Canada) was used.

Photometric Nucleotide Sugar Determination
------------------------------------------

Assays for UDP-Glc, UDP-GlcUA and UDP-Xyl were linear up to 500 μM of the respective compound, and samples were diluted accordingly prior to analysis.

UDP-Glc was detected using a coupled enzymatic assay of GOD and POD.\[[@b24]\] UDP-Glc was hydrolyzed by addition of glacial acetic acid to the samples, yielding a final concentration of 28.5%, and heating to 99 °C for 10 min. Afterwards, the assay was performed using the hydrolyzed samples containing free glucose. Absorption at *λ*=420 nm was measured on a Beckman-Coulter DU800 spectrophotometer.

Concentration of UDP-GlcUA was determined using a colorimetric assay described elsewhere.\[[@b25]\] Absorption (*λ*=525 nm) was measured on a Beckman-Coulter DU800 spectrophotometer.

UDP-Xyl was determined according to the method of Roe and Rice.\[[@b26]\] A hydrolysis step to allow detection of the UDP sugar was performed prior to the colorimetric assay, as described for UDP-Glc. Measurement was done using the same settings as described for UDP-GlcUA.

Preparative Anion Exchange Chromatography
-----------------------------------------

Purification of the produced sugar nucleotide was done using a cooled (4 °C) BioLogic DuoFlow system (Bio-Rad, Vienna, Austria) equipped with a 6-mL Resource Q anion exchange column. A step-wise gradient of 6 mL min^−1^ NH~4~HCO~2~ (buffer A: 20 mM and buffer B: 500 mM) was used for elution of bound compounds. The steps were as follows: 24 mL NH~4~HCO~2~ 58 mM, 30 mL NH~4~HCO~2~ 106 mM, 24 mL NH~4~HCO~2~ 500 mM. Prior to each run, the column was regenerated by flushing with three column volumes buffer B and buffer A, respectively. UV absorption (*λ*=254 nm) was used to detect the compounds, which were collected in 6 mL fractions.

The total volume of UDP-Xyl-containing fractions was 48 mL from one reaction batch, which was concentrated to 2 mL on a rotary evaporator (40 °C, 20 mbar) before proceeding with size exclusion chromatography.

Preparative Size Exclusion Chromatography
-----------------------------------------

NH~4~HCO~2~ was removed from concentrated UDP-Xyl fractions on a BioLogic DuoFlow system (Bio-Rad) using a self-packed Sephadex G-10 (GE Healthcare) column (bed volume=53 mL, H/D ratio=3.8). Elution was performed with deionized water using a flow rate of 2 mL min^−1^. UDP-Xyl was detected by UV absorption (*λ*=254 nm), while conductivity measurement was used for NH~4~HCO~2~ detection. Automated fraction collection was used to collect 10.5 mL of pure UDP-Xyl solution. The water was finally removed on a rotary evaporator (40 °C, 3 mbar).
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